Simpler Grants.gov #HT942526PCARPTRPA

Pancreatic Cancer Translational Research Partnership Grant Solicitation

This opportunity invites collaborative research proposals to advance pancreatic cancer research toward clinical applications. - Government Buyer: - Department of the Army, US Army Medical Research Acquisition Activity (USAMRAA) - Defense Health Agency, Congressionally Directed Medical Research Programs (CDMRP) - Program Details: - FY26 Pancreatic Cancer Research Program Translational Research Partnership Award - Supports partnerships among clinicians, population scientists, applied scientists, and basic scientists - Requires two Principal Investigators (Initiating PI and Partnering PI), with at least one expert in pancreatic cancer research or patient care - Preliminary data supporting feasibility is required - Research must address at least one FY26 PCARP Focus Area (e.g., early detection, biomarkers, new therapeutic targets) - Eligible Research Activities: - Retrospective tissue analysis - Correlative studies - Pilot clinical trials - Large-scale clinical trials are excluded - Funding and Performance: - Approximately six awards anticipated - Combined budget cap of $6.6 million (up to $1.10 million per award) - Maximum period of performance is three years - Unique Requirements: - Two-step application process - Must include preliminary data and specific expertise - No OEMs or commercial vendors are specified, as this is a grant for research partnerships rather than product procurement.

Description

The FY26 Pancreatic Cancer Research Program (PCARP) Translational Research Partnership Award supports partnerships among clinicians, population scientists, applied scientists, and basic scientists to accelerate promising pancreatic cancer research toward clinical applications. The partnership must include at least one member with expertise in pancreatic cancer research or patient care and address at least one FY26 PCARP Focus Area. The award requires preliminary data supporting the feasibility of the research hypothesis and approaches, allowing retrospective tissue analysis, correlative studies, and pilot clinical trials but not large-scale clinical trials. Two Principal Investigators are required: an Initiating PI who submits a pre-application and both PIs who submit full applications. Applications may be withdrawn if either application is rejected or withdrawn.

View original listing